(Q36449160)

14 August 2017

1 reference

title

Noninvasive diagnosis of liver fibrosis in patients with chronic hepatitis C. (English)

1 reference

14 August 2017

Jean-Michel Pawlotsky

series ordinal

2

object named as

Jean-Michel Pawlotsky

0 references

author name string

Laurent Castera

series ordinal

1

1 reference

PubMed ID

16614661

14 August 2017

Jean-Michel Pawlotsky

series ordinal

2

1 reference

14 August 2017

9 November 2005

1 reference

MedGenMed : Medscape general medicine

14 August 2017

1 reference

14 August 2017

7

1 reference

14 August 2017

4

1 reference

14 August 2017

39

1 reference

Serum matrix metalloproteinase-1 in patients with chronic viral hepatitis

14 August 2017

1 reference

12 December 2020

Ultrasonographic diagnosis of hepatic fibrosis or cirrhosis

1 reference

12 December 2020

Pain experienced during percutaneous liver biopsy

1 reference

12 December 2020

Serum laminin and type IV collagen are accurate markers of histologically severe alcoholic hepatitis in patients with cirrhosis

1 reference

12 December 2020

Serum YKL-40 is increased in patients with hepatic fibrosis

1 reference

12 December 2020

Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF).

1 reference

12 December 2020

Need for validation of clinical decision aids: use of the AST/ALT ratio in predicting cirrhosis in chronic hepatitis C.

1 reference

12 December 2020

1 reference

12 December 2020

Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study

1 reference

12 December 2020

Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection

1 reference

12 December 2020

Diagnostic potential of circulating TIMP-1 and MMP-2 as markers of liver fibrosis in patients with chronic hepatitis C

1 reference

12 December 2020

Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial

1 reference

12 December 2020

Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model

1 reference

12 December 2020

Biochemical markers of liver fibrosis: a comparison with historical features in patients with chronic hepatitis C.

1 reference

12 December 2020

Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection

1 reference

12 December 2020

National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002--June 10-12, 2002.

1 reference

12 December 2020

Noninvasive monitoring of patients with chronic hepatitis C.

1 reference

12 December 2020

A prospective assessment of the inter-laboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease

1 reference

12 December 2020

Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients

1 reference

12 December 2020

Clinical use of hyaluronic acid as a predictor of fibrosis change in hepatitis C.

1 reference

12 December 2020

Biochemical markers of fibrosis in patients with chronic hepatitis C: a comparison with prothrombin time, platelet count, and age-platelet index

1 reference

12 December 2020

Diagnosing fibrosis in hepatitis C: Is the pendulum swinging from biopsy to blood tests?

1 reference

12 December 2020

Sampling Variability on Percutaneous Liver Biopsy in Patients with Chronic Hepatitis C Virus Infection

1 reference

12 December 2020

Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease

1 reference

12 December 2020

Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin

1 reference

12 December 2020

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

1 reference

12 December 2020

Sampling variability of liver fibrosis in chronic hepatitis C.

1 reference

12 December 2020

Transient elastography: a new noninvasive method for assessment of hepatic fibrosis.

1 reference

12 December 2020

Circulating matrix metalloproteinases 1, 2, 9 and their inhibitors TIMP-1 and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: comparison with PIIINP and hyaluronic acid.

1 reference

12 December 2020

Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors

1 reference

12 December 2020

Improved prediction of fibrosis in chronic hepatitis C using measures of insulin resistance in a probability index

1 reference

12 December 2020

Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics

1 reference

12 December 2020

Evaluation of liver fibrosis: a concise review

1 reference

12 December 2020

Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C.

1 reference

12 December 2020

Intra-individual fasting versus postprandial variation of biochemical markers of liver fibrosis (FibroTest) and activity (ActiTest)

1 reference

12 December 2020

Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C

1 reference

12 December 2020

Serum markers detect the presence of liver fibrosis: a cohort study.

1 reference

12 December 2020

Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients.

1 reference

12 December 2020

Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

1 reference

12 December 2020

Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C.

1 reference

12 December 2020

Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study

1 reference

12 December 2020

Independent prospective multicenter validation of biochemical markers (fibrotest-actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C: the fibropaca study.

1 reference

12 December 2020

Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver

1 reference

12 December 2020

Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group

1 reference

12 December 2020

Diagnostic accuracy of hyaluronan and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis

1 reference

12 December 2020

Transforming growth factor-beta 1 in chronic hepatitis C.

1 reference

12 December 2020

Noninvasive diagnosis of hepatic fibrosis or cirrhosis

1 reference

12 December 2020

What is the criterion for differentiating chronic hepatitis from compensated cirrhosis? A prospective study comparing ultrasonography and percutaneous liver biopsy

1 reference

12 December 2020

Histopathological evaluation of liver fibrosis: quantitative image analysis vs semi-quantitative scores. Comparison with serum markers.

1 reference

12 December 2020

Factors associated with serum alanine transaminase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C. MULTIVIRC Group.

1 reference

12 December 2020

Identifiers

PubMed ID

16614661

1 reference

PubMed ID

16614661